Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ISSN-L : 0918-8959
Impaired Feedback Inhibition of Insulin Secretion by Hyperinsulinemia in Patients with Insulinoma
SHINSUKE HIRAMATSUYASUHIRO SAKOKAZUO MIMURAYASUHIRO ONOKENICHI IWASHIGESUSUMU TANIGUCHIFUMIO UMEDAHAJIME NAWATA
著者情報
ジャーナル フリー

1995 年 42 巻 1 号 p. 39-42

詳細
抄録

By means of the euglycemic three step hyperinsulinemic clamp technique, suppression of endogenous C-peptide secretion by exogenous insulin infusion was evaluated in patients with insulinoma (n=8) and healthy controls (n=20). Euglycemic hyperinsulinemic clamp studies were performed with an artificial pancreas (STG-22 NIKKISO, Tokyo, Japan). Insulin (Actrapid human insulin) was infused at the rate of 1.12, 3, and 10mU/kg/min. Plasma glucose levels were clamped at 80mg/dl, and high insulin levels were maintained in all subjects (833±78μU/ml at the rate of 10mU/kg/min insulin infusion). During the clamp studies, plasma C-peptide levels in normal subjects declined from 2.0±0.2 to 0.9±0.2ng/ml, indicating suppression of endogenous insulin secretion by exogenous insulin infusion. In patients with insulinoma, plasma C-peptide levels were 3.1±1.6ng/ml in the basal state, and were not suppressed even during exogenous hyperinsulinemia. We concluded that the feedback inhibition of insulin secretion by exogenous insulin infusion is attenuated in patients with insulinoma, and that the hyperinsulinemic clamp technique may be a useful method for the diagnosis of insulinoma.

著者関連情報
© The Japan Endocrine Society
前の記事 次の記事
feedback
Top